GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer
GSK-3 抑制剂 elraglusib 可增强肿瘤活检中的肿瘤浸润免疫细胞活化,并在小鼠结肠直肠癌模型中与抗 PD-L1 产生协同作用
期刊:
影响因子:
doi:10.1101/2023.02.07.527499
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, Brittany A Borden, Francis J Giles, Mark Dooner, Benedito A Carneiro, Wafik S El-Deiry